Evaluation of UVA-mediated oxidative damage to proteins and lipids in extracorporeal photoimmunotherapy.
The combination of UVA and 8-methoxypsoralen (8-MOP) is known for the ability to produce reactive oxygen species (ROS) that react subsequently with DNA, lipids and proteins. In most studies concerned with UVA effects mediated by free radicals, UVA doses higher than those exhibiting beneficial clinical results in extracorporeal photoimmunotherapy (ECPI) were used. The present study was undertaken to determine markers of oxidative stress in plasma and cells from the buffy coat using conditions relevant for ECPI (cumulative UVA dose at the sample level < or = 2 J/cm2). Plasma exposed to UVA of 20 J/cm2 resulted in protein oxidation as well in crosslinking and fragmentation revealed by electrophoresis. Exposure of the buffy coat and plasma to considerably lower doses of UVA (up to 2 J/cm2) combined with various 8-MOP concentrations resulted neither in an increase of malondialdehyde as a marker of lipid peroxidation nor in a changed electrophoretic protein pattern. In these same experiments the total antioxidative capacity decreased to 65% of the initial value, suggesting that the antioxidative defense of plasma is able to cope with oxidative stress under ECPI conditions. These results were confirmed by data from 10 patients with scleroderma or cutaneous T-cell lymphoma during ECPI treatment. The present results suggest that, although ROS are formed during ECPI, gross oxidative damage does not occur. It is, however, possible, that specific effects mediated by oxygen radicals may co-trigger the photoimmunomodulatory effects of ECPI.
Reinheckel
T
T
Department of Surgery, Otto-von-Guericke University, Magdeburg, Germany.
Bohne
M
M
Halangk
W
W
Augustin
W
W
Gollnick
H
H
D001798:Blood Proteins / Q000528:radiation effects*; D004307:Dose-Response Relationship, Radiation; D005069:Evaluation Studies as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D015227:Lipid Peroxidation / Q000528:radiation effects; D008055:Lipids / Q000528:radiation effects*; D016399:Lymphoma, T-Cell / Q000097:blood / Q000628:therapy; D018384:Oxidative Stress; D010778:Photochemotherapy / Q000379:methods*; D012595:Scleroderma, Systemic / Q000097:blood / Q000628:therapy; D014466:Ultraviolet Rays
D001798:Blood Proteins; D008055:Lipids